Next Generation Cell Therapy Market, By Cell Type, By Therapy Type, By Source, By Application, By End User, By Geography

Description

Next Generation Cell Therapy Market is estimated to be valued at USD 7.40 Bn in 2026 and is expected to reach USD 35.88 Bn by 2033, growing at a compound annual growth rate (CAGR) of 25.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7.40 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	25.30%	2033 Value Projection:	USD 35.88 Bn

The global next generation cell therapy market encompasses advanced therapies that utilize living cells to repair, replace or regenerate damaged tissues and treat complicated diseases. These therapies include CAR-T, NK cell, iPSC-derived and gene edited cell therapies with applications across oncology, auto-immune disorders, cardiovascular diseases and rare genetic conditions.

Advances in synthetic biology, CRISPR-based genome engineering and cell manufacturing are driving these therapies from research to clinical and commercial applications, while increasing regulatory support, improving manufacturing scalability and increased investment in advanced cellular technologies are further accelerating the development and adoption of next generation cell therapies globally.

Market Dynamics

The global next generation cell therapy market is driven by the increasing incidence of cancer and chronic diseases, increasing clinical validation of engineered cell therapies and advancements in gene-editing technologies such as CRISPR-Cas9 and base editing. Increasing regulatory support, government funding and development of allogeneic "off-the-shelf" therapies are other factors that are accelerating commercialization and expanding patient accessibility.

However, a number of constraints are present in the market, such as high manufacturing costs, complex personalized production, cold-chain requirements and stringent quality controls. Nevertheless, significant opportunities exist within allogeneic cell therapies, AI-enabled manufacturing and patient selection and expansion into solid tumors, autoimmune diseases and neurological disorders supported by increasing collaboration across biotechnology, pharmaceutical and research organizations.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global next generation cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Johnson & Johnson, Legend Biotech Corporation, Autolus Therapeutics plc, Iovance Biotherapeutics, Inc., Adaptimmune Therapeutics plc, Allogene Therapeutics, Inc., and CRISPR Therapeutics AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global next generation cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation cell therapy market

Market Segmentation

Cell Type Insights (Revenue, USD Bn, 2021 - 2033)
- T Cells
- Natural Killer (NK) Cells
- Stem Cells
- Dendritic Cells
- Macrophages
- Others
Therapy Type Insights (Revenue, USD Bn, 2021 - 2033)
- CAR-T Cell Therapy
- T-Cell Receptor (TCR) Therapy
- Tumor-Infiltrating Lymphocyte (TIL) Therapy
- CAR-NK Cell Therapy
- Stem Cell Therapy
- Others
Source Insights (Revenue, USD Bn, 2021 - 2033)
- Autologous
- Allogeneic
Application Insights (Revenue, USD Bn, 2021 - 2033)
- Hematological Malignancies
- Solid Tumors
- Autoimmune Diseases
- Genetic Disorders
- Neurological Disorders
- Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Cancer Centers
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutes
- Specialized Cell Therapy Centers
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- Bristol-Myers Squibb Company
- Gilead Sciences, Inc.
- Johnson & Johnson
- Legend Biotech Corporation
- Autolus Therapeutics plc
- Iovance Biotherapeutics, Inc.
- Adaptimmune Therapeutics plc
- Allogene Therapeutics, Inc.
- CRISPR Therapeutics AG

Product Code: CMI10150

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Next Generation Cell Therapy Market, By Cell Type
- Global Next Generation Cell Therapy Market, By Therapy Type
- Global Next Generation Cell Therapy Market, By Source
- Global Next Generation Cell Therapy Market, By Application
- Global Next Generation Cell Therapy Market, By End User
- Global Next Generation Cell Therapy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Cell Type Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global Next Generation Cell Therapy Market, By Cell Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
T Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Natural Killer (NK) Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Dendritic Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Macrophages
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Next Generation Cell Therapy Market, By Therapy Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
CAR-T Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
T-Cell Receptor (TCR) Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tumor-Infiltrating Lymphocyte (TIL) Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
CAR-NK Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Next Generation Cell Therapy Market, By Source, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Next Generation Cell Therapy Market, By Application, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hematological Malignancies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Solid Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Next Generation Cell Therapy Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Cancer Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Specialized Cell Therapy Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Next Generation Cell Therapy Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Gilead Sciences, Inc.
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Legend Biotech Corporation
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Autolus Therapeutics plc
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Iovance Biotherapeutics, Inc.
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Adaptimmune Therapeutics plc
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Allogene Therapeutics, Inc.
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies
CRISPR Therapeutics AG
- Company Highlights
- Cell Type Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us